Inamed is a CRO, specilized in the area of respiratory drug delivery and inhalation medicine, providing its clients with the full range of services, required for the planning, conduct and evaluation of clinical trials throughout all phases, for nearly two decades. Complementing our solid experience in conducting clinical trials, Inamed's team of inhalation and clinical experts provides our sponsors with a unique spectrum of services. Besides our clinical trial operations (phase II-IV) and state-of the-art, in-house clinical pharmacology unit (phase I-IIa) with 24 beds (+6 intensive monitoring beds), Inamed performs in-vitro studies in its own labs and is a leading CRO in continental Europe able and approved to perform scintigraphy studies, with radiolabeled compounds, under GMP requirements. Our studies deliver the highest quality data and can enhance your clinical trials and development projects for drugs and inhalation devices. Inamed offers an opportunity for sponsors to get their products to market more successfully.
Already in early phase clinical trials our sponsors benefit from Inamed’s inhalation specialty focus and our interdisciplinary collaboration between in-vitro experts and clinical scientist.Read more
Mastering the logistics of studies, which are becoming more and more complex, is the key to the success of your clinical trial. Our clients benefit from Inamed's long-term experience in dealing with highly complex studies.Read more
Besides the regular clinical trials in phase I-IV Inamed is a marked leader in specilized clinical trials with inhalation devices. Using our proprietary system Inamed can conduct high quality PIFR studies.Read more